NISTRI, SILVIA
 Distribuzione geografica
Continente #
EU - Europa 5.444
NA - Nord America 3.882
AS - Asia 655
AF - Africa 17
OC - Oceania 4
Totale 10.002
Nazione #
US - Stati Uniti d'America 3.876
PL - Polonia 3.236
RU - Federazione Russa 902
IT - Italia 312
IE - Irlanda 306
SE - Svezia 296
SG - Singapore 175
HK - Hong Kong 166
CN - Cina 124
UA - Ucraina 106
DE - Germania 102
FI - Finlandia 74
VN - Vietnam 57
IN - India 48
JO - Giordania 46
GB - Regno Unito 43
TR - Turchia 31
CH - Svizzera 30
CI - Costa d'Avorio 11
FR - Francia 10
KR - Corea 8
NL - Olanda 8
CA - Canada 6
AT - Austria 5
ES - Italia 4
SC - Seychelles 4
BE - Belgio 3
NZ - Nuova Zelanda 3
RO - Romania 3
AU - Australia 1
BJ - Benin 1
CZ - Repubblica Ceca 1
GR - Grecia 1
LT - Lituania 1
MU - Mauritius 1
NO - Norvegia 1
Totale 10.002
Città #
Warsaw 3.236
Fairfield 631
Ashburn 310
Chandler 307
Dublin 306
Woodbridge 300
Seattle 258
Cambridge 241
Houston 230
Wilmington 207
Jacksonville 178
Santa Clara 166
Singapore 139
Florence 110
Altamura 102
Hong Kong 98
Lawrence 95
Princeton 86
Ann Arbor 66
Boardman 55
Boston 54
Dong Ket 54
Falls Church 39
Medford 39
Mumbai 37
San Diego 36
Izmir 30
Bern 29
Beijing 27
Moscow 23
Shanghai 21
Dearborn 20
Phoenix 19
Buffalo 18
New York 18
Norwalk 15
Abidjan 11
Munich 11
Milan 10
Kent 9
Andover 8
Bremen 8
Guangzhou 8
Tappahannock 8
Hillsboro 7
London 7
Seoul 7
Yubileyny 7
Los Angeles 6
West Jordan 6
Frankfurt Am Main 5
Fuzhou 5
Helsinki 5
Toronto 5
Vienna 5
Barcelona 4
Kunming 4
Pune 4
Valeggio Sul Mincio 4
Auburn Hills 3
Brussels 3
Groningen 3
Laurel 3
Livorno 3
Mykolayiv 3
Nanjing 3
Poppi 3
Rome 3
Salerno 3
Timisoara 3
Cardiff 2
Chiswick 2
Clifton 2
Kilburn 2
Messina 2
Montevarchi 2
Naaldwijk 2
Naples 2
Napoli 2
Paris 2
Prato 2
Rotorua 2
Rubano 2
Verona 2
Zhengzhou 2
Acton 1
Athens 1
Brisbane 1
Calenzano 1
Central 1
Changsha 1
Chongqing 1
Christchurch 1
Cotonou 1
Dubendorf 1
Frankfurt am Main 1
Grevenbroich 1
Ho Chi Minh City 1
Hounslow 1
Impruneta 1
Totale 7.832
Nome #
Relaxin protects cardiac muscle cells from hypoxia/reoxygenation injury: involvement of the Notch-1 pathway 289
Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation through the paracrine release of VEGF. 263
Anti-inflammatory effects of low molecular weight heparin derivative in a rat model of carrageenan-induced pleurisy. 258
Reversal by relaxin of altered ileal spontaneous contractions in dystrophic (mdx) mice through a nitric oxide-mediated mechanism 253
Relaxin prevents cardiac fibroblast-myofibroblast transition via Notch-1-mediated Inhibition of TGF-β/Smad3 signaling 250
Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs. 248
Protection from cigarette smoke-induced vascular injury by recombinant human relaxin-2 (serelaxin) 245
EFFECTS OF RELAXIN ON VASCULAR SMOOTH MUSCLE AND ENDOTHELIAL CELLS IN NORMOTENSIVE AND HYPERTENSIVE RATS 237
Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. 235
Ceramide: a key signaling molecule in a Guinea pig model of allergic asthmatic response and airway inflammation. 228
Relaxin promotes growth and maturation of mouse neonatal cardiomyocytes in vitro. clues for cardiac regeneration. 226
Pretreatment with Relaxin Does Not Restore NO-Mediated Modulation of Calcium Signal in Coronary Endothelial Cells Isolated from Spontaneously Hypertensive Rats 216
Relaxin inhibits lipopolysaccharide-induced adhesion of neutrophils to coronary endothelial cells by a nitric oxide-mediated mechanism. 216
Functional and histopathological improvement of the post-infarcted rat heart upon myoblast cell grafting and relaxin therapy*. * Bonacchi and Nistri contributed equally to this article 214
Pretreatment with relaxin does not restore no-mediated modulation of calcium signal in coronary endothelial cells isolated from spontaneously hypertensive rats 213
Notch signaling in ischemic damage and fibrosis: evidence and clues from the heart 213
New insights into the morphogenic role of stromal cells and their relevance for regenerative medicine. Lessons from the heart. 211
Epigallocatechine-3-gallate reduces allergen-induced asthma-like reaction in sensitised guinea pigs. 210
oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and post-ischemic myocardial injury 199
Paracrine effects of transplanted myoblasts and relaxin on post-infarction heart remodeling 197
A Fluorescent Silver(I) Carbene Complex with Anticancer Properties: Synthesis, Characterization, and Biological Studies 195
Different Antioxidant Efficacy of Two MnII-Containing Superoxide Anion Scavengers on Hypoxia/Reoxygenation-Exposed Cardiac Muscle Cells 193
Relaxin receptors and nitric oxide synthases. Search for the missing link. 182
High-yield method for isolation and culture of endothelial cells from rat coronary blood vessels suitable for analysis of intracellular calcium and nitric oxide biosynthetic pathway. 178
Relaxin up regulates inducile nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial 165
Adiponectin Exerts Peripheral Inhibitory Effects on the Mouse Gastric Smooth Muscle through the AMPK Pathway 143
Effect of a plant histaminase on asthmalike reaction induced by inhaled antigen in sensitized guinea pig. 142
Protection from Cigarette Smoke-Induced Lung Dysfunction and Damage by H2 Relaxin (Serelaxin) 135
A selective H4R antagonist prevents antigen-induced asthma-like reaction and airway inflammation in guinea pigs. 130
Role of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxin 129
Relaxin induces up-regulation of ADAM10 metalloprotease in RXFP1-expressing cells by PI3K/AKT signaling 127
A novel, simple bioactivity assay for relaxin based on inhibition of platelet aggregation. 118
Inhibitory effects of relaxin on cardiac fibroblast-to-myofibroblast transition: An electrophysiological study 116
Morphofunctional integration between skeletal myoblasts and adult cardiomyocytes in coculture is favored by direct cell-cell contacts and relaxin treatment. 115
Activation of cannabinoid receptors reduces allergen-induced oxidative stress damage during asthma-like reaction in sensitised guinea-pigs. 115
Depression by relaxin of neurally induced contractile responses in the mouse gastric fundus. 113
Novel drug development opportunity for relaxin in acute myocardial infarction. evidences from a swine model. 109
A new low molecular weight, Mn(II)-containing scavenger of superoxide anion protects cardiac muscle cells from hypoxia/reoxygenation injury. 107
Effect of cigarette smoke and treatment with relaxin on Guinea pig skin 107
Altered nitric oxide calcium responsiveness of aortic smooth muscle cells in spontaneously hypertensive rats depends on low expression of cyclic guanosine monophosphate-dependent protein kinase type I 103
HUMAN RECOMBINANT RELAXIN REDUCES HEART INJURY AND IMPROVES VENTRICULAR PERFORMANCE IN A SWINE MODEL OF ACUTE MYOCARDIAL INFARCTION. 102
Relaxin inhibits the activation of human neutrophils: involvement of the nitric oxide pathway 102
BASIC PROGRESS AND FUTURE THERAPEUTIC PERSPECTIVES OF RELAXIN IN ISCHEMIC HEART DISEASE. 102
Relaxin affects smooth muscle biophysical properties and mechanical activity of the female mouse colon. 98
Protection of coronary endothelial cells from cigarette smoke-induced oxidative stress by a new MnII-containing polyamine-polycarboxilate scavenger of superoxide anion 98
Relaxin induces mast cell inhibition and reduces ventricular arrhythmias in a swine model of acute myocardial infarction. 95
Mast cell inhibition and reduced ventricular arrhythmias in a swine model of acute myocardial infarction upon therapeutic administration of relaxin. 87
The vasorelaxant hormone relaxin induces changes in liver sinusoid microcirculation. A morphologic study in the rat. 84
Mesenchymal stromal cells affect cardiomyocyte growth through juxtacrine Notch-1/Jagged-1 signaling and paracrine mechanisms: clues for cardiac regeneration. 84
Relaxin up-regulates the nitric oxide biosynthetic pathway in the mouse uterus: involvement in the inhibition of myometrial contractility 84
Relaxin causes changes of the liver. In vivo studies in rats. 83
Skeletal myoblasts overexpressing relaxin improve differentiation and communication of primary murine cardiomyocyte cell cultures. 82
Relaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells. 82
Relaxin as a cardiovascular hormone. Physiology, pathophysiology and therapeutic promises. 79
Relaxin depresses small bowel motility through a nitric oxide-mediated mechanism. Studies in mice. 74
Cardiac anaphylaxis: pathophysiology and therapeutical perspectives. 73
Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation in vitro: therapeutic potential for muscle repair/regeneration. 72
Effect of a plant histaminase on asthmalike reaction induced by inhaled antigen in sensitised guinea pig. 71
Inducible nitric oxide synthase expression in human colorectal cancer - Correlation with tumor angiogenesis 70
Relaxin promotes differentiation of human breast cancer cells MCF-7 transplanted into nude mice 70
Up-Regulation of Inducible Nitric Oxide Synthase by Relaxin in Rat Coronary Endothelial Cells is Not Mediated by Proinflammatory Cytokines. 70
Relaxin in vascular physiology and pathophysiology: possible implications in ischemic brain disease. 68
Human relaxin-2 (Serelaxin) attenuates oxidative stress in cardiac muscle cells exposed in vitro to hypoxia–reoxygenation. evidence for the involvement of reduced glutathione up-regulation 66
Effects of relaxin on nitrergic neurotransmission in the mouse gastric fundus. 65
Chronic Exposure to Cigarette Smoke Affects the Ileum and Colon of Guinea Pigs Differently. Relaxin (RLX-2, Serelaxin) Prevents Most Local Damage 62
Cardiac progenitor mesenchymal stem cell interaction: new perspectives for myocardial repair/regeneration 60
Prominent role of relaxin in improving post-infarction heart remodelling. Clues from in vivo and in vitro studies with genetically engineered relaxin-producing myoblasts. 60
Evaluation of coumarin-tagged deferoxamine as a Zr(IV)-based PET/fluorescence dual imaging probe 56
Relaxin antagonizes the effects of TGF-β/Smad3 axis on cardiac fibroblast-myofibroblast transition through the upregulation of Notch-1 signalling 51
Evidence that resistin acts on the mechanical responses of the mouse gastric fundus 48
Relaxin inhibits activation of human neutrophils in vitro by a nitric oxide dependent mechanism 48
Synthetic short-chain peptide analogues of H1 relaxin lack affinity for the RXFP1 receptor and relaxin-like bioactivity. Clues to a better understanding of relaxin agonist design 48
Restoring nitric oxide cytosolic calcium regulation by cyclic GMP protein kinase Ialpha transfection in coronary endothelial cells of spontaneously hypertensive rats 47
Relaxin promotes proliferation and maturation of mouse neonatal cardiomyocites in vitro. Possible implications for cardiac regenerative medicine. 46
Relaxin inhibits lipopolysaccharide-induced adhesion of neutrophilis to coronary endothelial cells by a nitric oxide-mediated mechanism 45
Relaxin, cardiac stem cells and heart regeneration 45
Relaxin, stem cells and cardiac regeneration 44
Relaxin promotes sphingolipid metabolism in primary cardiac cells and h9c2 cardio myoblasts. Role in metalloproteinase expression/ release 41
Mesenchymal stromal cells stimulate C2C12 myoblast cell proliferation: potential relevance in skeletal muscle regeneration. 38
Porcine relaxin but not serelaxin shows residual bioactivity after in vitro simulated intestinal digestion — Clues for the development of new relaxin peptide agonists suitable for oral delivery 37
Human Recombinant Relaxin (Serelaxin) as Anti-fibrotic Agent: Pharmacology, Limitations and Actual Perspectives 34
Neuronal Nitric Oxide Synthase as a Shared Target for the Effects of Adiponectin and Resistin on the Mechanical Responses of the Mouse Gastric Fundus 31
Adiponectin affects ileal contractility of mouse preparations 30
Serelaxin Protects H9c2 Cardiac Myoblasts against Hypoxia and Reoxygenation-Induced Damage through Activation of AMP Kinase/Sirtuin1: Further Insight into the Molecular Mechanisms of the Cardioprotection of This Hormone 29
Totale 10.204
Categoria #
all - tutte 25.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.854


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.366 0 0 0 0 227 212 194 247 168 112 180 26
2020/20211.605 107 137 53 245 127 175 107 109 134 253 59 99
2021/2022599 39 76 27 13 33 42 28 30 29 42 107 133
2022/20231.437 129 275 41 110 105 243 200 74 160 4 51 45
2023/2024481 22 58 83 27 34 55 12 121 9 17 24 19
2024/20251.386 109 335 232 552 158 0 0 0 0 0 0 0
Totale 10.204